trabectedin
SpainDrugs containing this active substance
-
It is used to treat advanced soft tissue sarcoma when other treatments have not worked or cannot be used. It is also used, together with another medication called pegylated liposomal doxorubicin (PLD), to treat ovarian cancer in patients who have experienced a relapse.
Form: powder for concentrate for solution for infusion
Active substance Dosage trabectedin 0,25 mg/ml Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat advanced soft tissue sarcoma when other treatments have not worked or cannot be used. It is also used, together with another medication called pegylated liposomal doxorubicin (PLD), to treat ovarian cancer in patients who have experienced a relapse.
Form: powder for concentrate for solution for infusion
Active substance Dosage trabectedin 0,25 mg/ml Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat advanced soft tissue sarcoma when other treatments have not worked or cannot be used. It is also used, together with another medication called pegylated liposomal doxorubicin (PLD), to treat ovarian cancer in patients who have experienced a relapse and are not resistant to platinum-based drugs.
Form: powder for concentrate for solution for infusion
Active substance Dosage trabectedin 0,25 mg Manufacturer: Ever Valinject Gmbh
-
It is used to treat advanced soft tissue sarcoma when other treatments have not worked or cannot be used. It is also used, together with another medication called pegylated liposomal doxorubicin (PLD), to treat ovarian cancer in patients who have had a relapse and are not resistant to platinum compounds.
Form: powder for concentrate for solution for infusion
Active substance Dosage trabectedin 1 mg Manufacturer: Ever Valinject Gmbh
-
It is used to treat advanced soft tissue sarcoma when other treatments have not worked or cannot be used. It is also used, together with another medication called pegylated liposomal doxorubicin (PLD), to treat ovarian cancer in patients who have experienced a relapse and are not resistant to platinum-based drugs.
Form: powder for concentrate for solution for infusion
Active substance Dosage trabectedin 0,25 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat advanced soft tissue sarcoma when other treatments have not worked or cannot be used. It is also used, together with another medication called pegylated liposomal doxorubicin (PLD), to treat ovarian cancer in patients who have had a relapse and are not resistant to platinum-based drugs.
Form: powder for concentrate for solution for infusion
Active substance Dosage trabectedin 1 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat advanced soft tissue sarcoma when other treatments have not worked or cannot be used. It is also used, together with another medication called DLP, to treat ovarian cancer in patients who have had a relapse and are not resistant to platinum-based drugs.
Form: powder for concentrate for solution for infusion
Active substance Dosage trabectedin 0,25 mg Manufacturer: Sun Pharmaceutical Industries (Europe) B.V.
-
It is used to treat advanced soft tissue sarcoma when other treatments have not worked or cannot be used. It is also used, in combination with another medication called DLP, to treat ovarian cancer in patients who have experienced a relapse.
Form: powder for concentrate for solution for infusion
Active substance Dosage trabectedin 1 mg Manufacturer: Sun Pharmaceutical Industries (Europe) B.V.
-
It is used to treat advanced soft tissue sarcoma when other treatments have not worked or cannot be used. It is also used, in combination with another medication called pegylated liposomal doxorubicin (PLD), to treat recurrent ovarian cancer.
Form: powder for concentrate for solution for infusion
Active substance Dosage trabectedin 0,25 mg Manufacturer: Teva B.V.
-
It is used to treat advanced soft tissue sarcoma when other treatments have not worked or cannot be used. It is also used, in combination with another medication called pegylated liposomal doxorubicin (PLD), to treat ovarian cancer in patients who have experienced a relapse.
Form: powder for concentrate for solution for infusion
Active substance Dosage trabectedin 1 mg Manufacturer: Teva B.V.
-
It is used to treat advanced soft tissue sarcoma when other treatments have not worked or cannot be used. It is also used, together with another medication called pegylated liposomal doxorubicin (PLD), to treat ovarian cancer in patients who have experienced a relapse.
Form: powder for concentrate for solution for infusion
Active substance Dosage trabectedin 0,25 mg Manufacturer: Pharma Mar S.A.
-
It is used to treat advanced soft tissue sarcoma when other treatments have not worked or cannot be used. It is also used, together with another medication called DLP, to treat ovarian cancer in patients who have experienced a relapse.
Form: powder for concentrate for solution for infusion
Active substance Dosage trabectedin 1 mg Manufacturer: Pharma Mar S.A.